Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Prescribing patterns and impact of glucagon-like peptide-1 receptor agonists in a kidney transplant evaluation cohort in British Columbia, Canada A single-center experience
Door Chae HH, Luo C, Harriman D en 1 anderen.
Inhoud in het Engels
Abstract
Introduction
Glucagon-like peptide-1 receptor agonists (GLP-1RA) have demonstrated weight loss and cardiometabolic benefits in specific subpopulations. Studies of GLP-1RAs in Canadian end-stage renal disease (ESRD) and kidney transplantation (KT) patients are limited.